Schedule 13G ownership disclosure
ATHIRA PHARMA INC
Common Stock, $0.0001 Par Value · CUSIP: 04746L104
Event date: 2025-12-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ACORN BIOVENTURES, L.P.
Shares: 210,730.00 · Class: 2.2%
- ACORN CAPITAL ADVISORS GP, LLC
Shares: 210,730.00 · Class: 2.2%
- ACORN BIOVENTURES 2, L.P.
Shares: 291,009.00 · Class: 3.0%
- Acorn Capital Advisors GP 2, LLC
Shares: 291,009.00 · Class: 3.0%
- Anders Hove
Shares: 501,739.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001636587-25-000065
- Form type
- SCHEDULE 13G
- Filer
- ACORN BIOVENTURES, L.P.
- CIK
- CIK 1766853
- Filed
- Dec 23, 2025
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13G beneficial ownership